How NT-proBNP differs from BNP as a heart failure marker
Автор: Roche
Загружено: 24 авг. 2018 г.
Просмотров: 29 354 просмотра
What makes NT-proBNP a good biomarker for early identification of heart failure? It's to do with the differences in how the body processes it.
To learn more about biomarkers and the role they play in the diagnosis and treatment of heart failure, visit https://www.roche.com/research_and_de...
Subscribe to our YouTube channel now: https://www.youtube.com/user/roche?su...
Get in touch with us:
https://www.roche.com/
/ rochecareers
/ roche
/ roche
Roche has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.
For more information and insights visit: https://www.roche.com/

Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: